RegentAtlantic Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $858K | Sell |
7,827
-31
| -0.4% | -$3.93K | 0.03% | 340 |
|
|
2022
Q2 | $1.04M | Sell |
7,858
-40
| -0.5% | -$5.25K | 0.03% | 310 |
|
|
2022
Q1 | $1.05M | Buy |
7,898
+14
| +0.2% | +$1.68K | 0.03% | 313 |
|
|
2021
Q4 | $918K | Buy |
7,884
+383
| +5% | +$45.1K | 0.03% | 339 |
|
|
2021
Q3 | $901K | Buy |
7,501
+536
| +8% | +$62.4K | 0.03% | 322 |
|
|
2021
Q2 | $834K | Buy |
6,965
+146
| +2% | +$16K | 0.03% | 323 |
|
|
2021
Q1 | $678K | Sell |
6,819
-228
| -3% | -$22.9K | 0.02% | 333 |
|
|
2020
Q4 | $705K | Buy |
7,047
+137
| +2% | +$14.5K | 0.03% | 288 |
|
|
2020
Q3 | $757K | Sell |
6,910
-75
| -1% | -$8.34K | 0.03% | 267 |
|
|
2020
Q2 | $739K | Buy |
6,985
+95
| +1% | +$9.81K | 0.04% | 260 |
|
|
2020
Q1 | $615K | Sell |
6,890
-76
| -1% | -$7.16K | 0.05% | 251 |
|
|
2019
Q4 | $695K | Buy |
6,966
+344
| +5% | +$32.4K | 0.04% | 272 |
|
|
2019
Q3 | $590K | Sell |
6,622
-94
| -1% | -$8.15K | 0.04% | 281 |
|
|
2019
Q2 | $554K | Sell |
6,716
-234
| -3% | -$18.3K | 0.04% | 286 |
|
|
2019
Q1 | $562K | Sell |
6,950
-465
| -6% | -$36.7K | 0.04% | 281 |
|
|
2018
Q4 | $563K | Sell |
7,415
-380
| -5% | -$29.7K | 0.05% | 265 |
|
|
2018
Q3 | $617K | Buy |
7,795
+262
| +3% | +$19.8K | 0.05% | 269 |
|
|
2018
Q2 | $529K | Sell |
7,533
-289
| -4% | -$20.8K | 0.05% | 267 |
|
|
2018
Q1 | $547K | Sell |
7,822
-13
| -0.2% | -$900 | 0.05% | 269 |
|
|
2017
Q4 | $544K | Buy |
7,835
+1
| +0% | +$67 | 0.04% | 273 |
|
|
2017
Q3 | $531K | Buy |
7,834
+45
| +0.6% | +$2.84K | 0.05% | 270 |
|
|
2017
Q2 | $531K | Sell |
7,789
-298
| -4% | -$19.5K | 0.05% | 268 |
|
|
2017
Q1 | $504K | Sell |
8,087
-965
| -11% | -$56.2K | 0.05% | 269 |
|
|
2016
Q4 | $495K | Sell |
9,052
-968
| -10% | -$55K | 0.05% | 271 |
|
|
2016
Q3 | $658K | Buy |
10,020
+769
| +8% | +$50.3K | 0.07% | 242 |
|
|
2016
Q2 | $559K | Sell |
9,251
-252
| -3% | -$14.6K | 0.05% | 251 |
|
|
2016
Q1 | $535K | Sell |
9,503
-1,231
| -11% | -$74K | 0.06% | 243 |
|
|
2015
Q4 | $729K | Sell |
10,734
-1,108
| -9% | -$72.6K | 0.08% | 213 |
|
|
2015
Q3 | $754K | Sell |
11,842
-873
| -7% | -$57.4K | 0.07% | 209 |
|
|
2015
Q2 | $810K | Sell |
12,715
-1,280
| -9% | -$87.6K | 0.07% | 205 |
|
|
2015
Q1 | $958K | Sell |
13,995
-1,832
| -12% | -$127K | 0.08% | 192 |
|
|
2014
Q4 | $1.11M | Sell |
15,827
-230
| -1% | -$16.5K | 0.09% | 176 |
|
|
2014
Q3 | $1.15M | Sell |
16,057
-2,720
| -14% | -$199K | 0.11% | 166 |
|
|
2014
Q2 | $1.4M | Sell |
18,777
-2,433
| -11% | -$176K | 0.13% | 152 |
|
|
2014
Q1 | $1.38M | Sell |
21,210
-9,438
| -31% | -$610K | 0.13% | 147 |
|
|
2013
Q4 | $1.82M | Buy |
30,648
+790
| +3% | +$42.9K | 0.18% | 126 |
|
|
2013
Q3 | $1.55M | Buy |
29,858
+1,243
| +4% | +$62.4K | 0.17% | 132 |
|
|
2013
Q2 | $1.35M | Buy |
+28,615
| New | +$1.46M | 0.16% | 132 |
|
Other funds holding AZN
RegentAtlantic Capital's AZN Position: Q3 2022 in Review
RegentAtlantic Capital reduced its AstraZeneca (AZN) stake by 0.39% in Q3 2022, selling an estimated $3.93K and leaving 7,827 shares worth $858K. The position accounts for 0.03% of the portfolio, ranked #340.
RegentAtlantic Capital first reported a position in AZN in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.82M in Q4 2013. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.
- RegentAtlantic Capital held 7,827 shares of AstraZeneca worth $858K as of Q3 2022.
- RegentAtlantic Capital sold 31 AstraZeneca shares in Q3 2022, an estimated $3.93K.
- AstraZeneca made up 0.03% of RegentAtlantic Capital's portfolio in Q3 2022, its #340 holding.
- RegentAtlantic Capital first reported a position in AstraZeneca in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's AstraZeneca position peaked at $1.82M in Q4 2013.
- 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.